• +1-646-491-9876
    • +91-20-67278686

    Search

    Age Related Macular Degeneration Pipeline Review H1 2017

    Age Related Macular Degeneration Pipeline Review H1 2017

    • Report Code ID: RW0001866815
    • Category Pharmaceuticals
    • No. of Pages 527
    • Publication Month Jun-17
    • Publisher Name Global Markets Direct
    Age Related Macular Degeneration - Pipeline Review, H1 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Age Related Macular Degeneration - Pipeline Review, H1 2017, provides an overview of the Age Related Macular Degeneration (Ophthalmology) pipeline landscape.

    Age related macular degeneration is the most common reason for vision loss in people aged above 50. It results in depreciation of the macula that may lead to distorted or blurry central vision. The predisposing factors involved are age, smoking, sunlight, heredity etc. Symptoms include development of blind spot and hazy vision. The condition may be treated by photodynamic therapy, radiation therapy and medication such as anti-angiogenic drugs.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Age Related Macular Degeneration - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Age Related Macular Degeneration (Ophthalmology) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Age Related Macular Degeneration (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Age Related Macular Degeneration and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 8, 31, 19, 4, 121, 30 and 1 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 15 and 3 molecules, respectively.

    Age Related Macular Degeneration (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Age Related Macular Degeneration (Ophthalmology) .
    - The pipeline guide reviews pipeline therapeutics for Age Related Macular Degeneration (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Age Related Macular Degeneration (Ophthalmology) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Age Related Macular Degeneration (Ophthalmology) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Age Related Macular Degeneration (Ophthalmology)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Age Related Macular Degeneration (Ophthalmology) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Age Related Macular Degeneration (Ophthalmology) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents
    Table of Contents 2
    Introduction 7
    Age Related Macular Degeneration - Overview 8
    Age Related Macular Degeneration - Therapeutics Development 9
    Age Related Macular Degeneration - Therapeutics Assessment 36
    Age Related Macular Degeneration - Companies Involved in Therapeutics Development 50
    Age Related Macular Degeneration - Drug Profiles 108
    Age Related Macular Degeneration - Dormant Projects 476
    Age Related Macular Degeneration - Discontinued Products 487
    Age Related Macular Degeneration - Product Development Milestones 489
    Appendix 503

    List of Tables

    Number of Products under Development for Age Related Macular Degeneration, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..1) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..2) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..3) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..4) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..5) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..6) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..7) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..8) , H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Products under Development by Companies, H1 2017
    Products under Development by Companies, H1 2017 (Contd..1) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..2) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..3) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..4) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..5) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..6) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..7) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..8) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..9) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..10) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..11) , H1 2017
    Products under Development by Universities/Institutes, H1 2017
    Number of Products by Stage and Target, H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..1) , H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..2) , H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..3) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..1) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..2) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..3) , H1 2017
    Number of Products by Stage and Route of Administration, H1 2017
    Number of Products by Stage and Molecule Type, H1 2017
    Age Related Macular Degeneration - Pipeline by 3SBio Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Abzena Plc, H1 2017
    Age Related Macular Degeneration - Pipeline by Achillion Pharmaceuticals Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Aciont Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Acucela Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by AdAlta Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by Adverum Biotechnologies Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Aerie Pharmaceuticals Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Aerpio Therapeutics Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Alcon Laboratories Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Alimera Sciences Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Alkeus Pharmaceuticals Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Allergan Plc, H1 2017
    Age Related Macular Degeneration - Pipeline by Allinky Biopharma, H1 2017
    Age Related Macular Degeneration - Pipeline by Alteogen Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Amakem NV, H1 2017
    Age Related Macular Degeneration - Pipeline by Amarna Therapeutics BV, H1 2017
    Age Related Macular Degeneration - Pipeline by Apellis Pharmaceuticals Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Apexigen Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Applied Genetic Technologies Corp, H1 2017
    Age Related Macular Degeneration - Pipeline by Astellas Pharma Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Benitec Biopharma Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by Biokine Therapeutics Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by Biomar Microbial Technologies, H1 2017
    Age Related Macular Degeneration - Pipeline by BioMAS Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by Biomics Biotechnologies Co Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by Biophytis SAS, H1 2017
    Age Related Macular Degeneration - Pipeline by BLR Bio LLC, H1 2017
    Age Related Macular Degeneration - Pipeline by Boehringer Ingelheim GmbH, H1 2017
    Age Related Macular Degeneration - Pipeline by Caladrius Biosciences Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Catalyst Biosciences Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Cell Cure Neurosciences Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by Cell Medica Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by Charlesson LLC, H1 2017
    Age Related Macular Degeneration - Pipeline by Chong Kun Dang Pharmaceutical Corp, H1 2017
    Age Related Macular Degeneration - Pipeline by Cipla Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by CJ HealthCare Corp, H1 2017
    Age Related Macular Degeneration - Pipeline by Clanotech AB, H1 2017
    Age Related Macular Degeneration - Pipeline by Coherus BioSciences Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Colby Pharmaceutical Company, H1 2017
    Age Related Macular Degeneration - Pipeline by Crinetics Pharmaceuticals Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Critical Pharmaceuticals Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by Daiichi Sankyo Company Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by Diffusion Pharmaceuticals Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Dong-A Socio Holdings Co Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by Eleven Biotherapeutics Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Elsalys Biotech SAS, H1 2017
    Age Related Macular Degeneration - Pipeline by Exonate Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by EyeGate Pharmaceuticals Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Eyevensys SAS, H1 2017
    Age Related Macular Degeneration - Pipeline by F. Hoffmann-La Roche Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by FirstString Research Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Foamix Pharmaceuticals Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by Formycon AG, H1 2017
    Age Related Macular Degeneration - Pipeline by Gene Techno Science Co Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by Genentech Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by GenSight Biologics SA, H1 2017
    Age Related Macular Degeneration - Pipeline by GlaxoSmithKline Plc, H1 2017
    Age Related Macular Degeneration - Pipeline by Graybug Vision Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by HanAll Biopharma Co Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by Huabo Biopharm Co Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by iCo Therapeutics Inc., H1 2017
    Age Related Macular Degeneration - Pipeline by Icon Bioscience Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Iconic Therapeutics Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Inception Sciences Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Innovent Biologics Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Intellect Neurosciences Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Ionis Pharmaceuticals Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Jeil Pharmaceutical Co Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by Johnson & Johnson, H1 2017
    Age Related Macular Degeneration - Pipeline by Just Biotherapeutics Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Kala Pharmaceuticals Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Kodiak Sciences Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Lead Discovery Center GmbH, H1 2017
    Age Related Macular Degeneration - Pipeline by LeadArtis SL, H1 2017
    Age Related Macular Degeneration - Pipeline by Lee's Pharmaceutical Holdings Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by Lupin Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by M's Science Corp, H1 2017
    Age Related Macular Degeneration - Pipeline by Mabion SA, H1 2017
    Age Related Macular Degeneration - Pipeline by MacuCLEAR Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Mitotech SA, H1 2017
    Age Related Macular Degeneration - Pipeline by Mitsubishi Tanabe Pharma Corp, H1 2017
    Age Related Macular Degeneration - Pipeline by Mor Research Application Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by Navya Biologicals Pvt Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by Neovacs SA, H1 2017
    Age Related Macular Degeneration - Pipeline by Neumedicines Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Novartis AG, H1 2017
    Age Related Macular Degeneration - Pipeline by NovelMed Therapeutics Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Ocular Therapeutix Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Ohr Pharmaceutical Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Omeros Corp, H1 2017
    Age Related Macular Degeneration - Pipeline by Ophthotech Corp, H1 2017
    Age Related Macular Degeneration - Pipeline by Oxford BioMedica Plc, H1 2017
    Age Related Macular Degeneration - Pipeline by PanOptica Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Paras Biopharmaceuticals Finland Oy, H1 2017
    Age Related Macular Degeneration - Pipeline by Pfenex Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Pfizer Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by PlantForm Corp, H1 2017
    Age Related Macular Degeneration - Pipeline by Promedior Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by pSivida Corp, H1 2017
    Age Related Macular Degeneration - Pipeline by Ra Pharmaceuticals Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Regeneron Pharmaceuticals Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by RegenxBio Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Ribomic Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by RXi Pharmaceuticals Corp, H1 2017
    Age Related Macular Degeneration - Pipeline by Samumed LLC, H1 2017
    Age Related Macular Degeneration - Pipeline by SanBio Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by SciFluor Life Sciences LLC, H1 2017
    Age Related Macular Degeneration - Pipeline by Stealth BioTherapeutics Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Sumitomo Dainippon Pharma Co Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by Sun Pharma Advanced Research Company Ltd, H1 2017
    Age Related Macular Degeneration - Pipeline by TRACON Pharmaceuticals Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Tyrogenex Inc, H1 2017
    Age Related Macular Degeneration - Pipeline by Wellstat Ophthalmics Corp, H1 2017
    Age Related Macular Degeneration - Pipeline by Xbrane Biopharma AB, H1 2017
    Age Related Macular Degeneration - Dormant Projects, H1 2017
    Age Related Macular Degeneration - Dormant Projects, H1 2017 (Contd..1) , H1 2017
    Age Related Macular Degeneration - Dormant Projects, H1 2017 (Contd..2) , H1 2017
    Age Related Macular Degeneration - Dormant Projects, H1 2017 (Contd..3) , H1 2017
    Age Related Macular Degeneration - Dormant Projects, H1 2017 (Contd..4) , H1 2017
    Age Related Macular Degeneration - Dormant Projects, H1 2017 (Contd..5) , H1 2017
    Age Related Macular Degeneration - Dormant Projects, H1 2017 (Contd..6) , H1 2017
    Age Related Macular Degeneration - Dormant Projects, H1 2017 (Contd..7) , H1 2017
    Age Related Macular Degeneration - Dormant Projects, H1 2017 (Contd..8) , H1 2017
    Age Related Macular Degeneration - Dormant Projects, H1 2017 (Contd..9) , H1 2017
    Age Related Macular Degeneration - Discontinued Products, H1 2017
    Age Related Macular Degeneration - Discontinued Products, H1 2017 (Contd..1) , H1 2017

    List of Figures

    Number of Products under Development for Age Related Macular Degeneration, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Number of Products by Top 10 Targets, H1 2017
    Number of Products by Stage and Top 10 Targets, H1 2017
    Number of Products by Top 10 Mechanism of Actions, H1 2017
    Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
    Number of Products by Top 10 Routes of Administration, H1 2017
    Number of Products by Stage and Top 10 Routes of Administration, H1 2017
    Number of Products by Top 10 Molecule Types, H1 2017
    Number of Products by Stage and Top 10 Molecule Types, H1 2017
    3SBio Inc
    Abzena Plc
    Achillion Pharmaceuticals Inc
    Aciont Inc
    Acucela Inc
    AdAlta Ltd
    Adverum Biotechnologies Inc
    Aerie Pharmaceuticals Inc
    Aerpio Therapeutics Inc
    Alcon Laboratories Inc
    Alimera Sciences Inc
    Alkeus Pharmaceuticals Inc
    Allergan Plc
    Allinky Biopharma
    Alteogen Inc
    Amakem NV
    Amarna Therapeutics BV
    Apellis Pharmaceuticals Inc
    Apexigen Inc
    Applied Genetic Technologies Corp
    Astellas Pharma Inc
    Benitec Biopharma Ltd
    Biokine Therapeutics Ltd
    Biomar Microbial Technologies
    BioMAS Ltd
    Biomics Biotechnologies Co Ltd
    Biophytis SAS
    BLR Bio LLC
    Boehringer Ingelheim GmbH
    Caladrius Biosciences Inc
    Catalyst Biosciences Inc
    Cell Cure Neurosciences Ltd
    Cell Medica Ltd
    Charlesson LLC
    Chong Kun Dang Pharmaceutical Corp
    Cipla Ltd
    CJ HealthCare Corp
    Clanotech AB
    Coherus BioSciences Inc
    Colby Pharmaceutical Company
    Crinetics Pharmaceuticals Inc
    Critical Pharmaceuticals Ltd
    Daiichi Sankyo Company Ltd
    Diffusion Pharmaceuticals Inc
    Dong-A Socio Holdings Co Ltd
    Eleven Biotherapeutics Inc
    Elsalys Biotech SAS
    Exonate Ltd
    EyeGate Pharmaceuticals Inc
    Eyevensys SAS
    F. Hoffmann-La Roche Ltd
    FirstString Research Inc
    Foamix Pharmaceuticals Ltd
    Formycon AG
    Gene Techno Science Co Ltd
    Genentech Inc
    GenSight Biologics SA
    GlaxoSmithKline Plc
    Graybug Vision Inc
    HanAll Biopharma Co Ltd
    Huabo Biopharm Co Ltd
    iCo Therapeutics Inc.
    Icon Bioscience Inc
    Iconic Therapeutics Inc
    Inception Sciences Inc
    Innovent Biologics Inc
    Intellect Neurosciences Inc
    Ionis Pharmaceuticals Inc
    Jeil Pharmaceutical Co Ltd
    Johnson & Johnson
    Just Biotherapeutics Inc
    Kala Pharmaceuticals Inc
    Kodiak Sciences Inc
    Lead Discovery Center GmbH
    LeadArtis SL
    Lee's Pharmaceutical Holdings Ltd
    Lupin Ltd
    M's Science Corp
    Mabion SA
    MacuCLEAR Inc
    Mitotech SA
    Mitsubishi Tanabe Pharma Corp
    Mor Research Application Ltd
    Navya Biologicals Pvt Ltd
    Neovacs SA
    Neumedicines Inc
    Novartis AG
    NovelMed Therapeutics Inc
    Ocular Therapeutix Inc
    Ohr Pharmaceutical Inc
    Omeros Corp
    Ophthotech Corp
    Oxford BioMedica Plc
    PanOptica Inc
    Paras Biopharmaceuticals Finland Oy
    Pfenex Inc
    Pfizer Inc
    PlantForm Corp
    Promedior Inc
    pSivida Corp
    Ra Pharmaceuticals Inc
    Regeneron Pharmaceuticals Inc
    RegenxBio Inc
    Ribomic Inc
    RXi Pharmaceuticals Corp
    Samumed LLC
    SanBio Inc
    SciFluor Life Sciences LLC
    Stealth BioTherapeutics Inc
    Sumitomo Dainippon Pharma Co Ltd
    Sun Pharma Advanced Research Company Ltd
    TRACON Pharmaceuticals Inc
    Tyrogenex Inc
    Wellstat Ophthalmics Corp
    Xbrane Biopharma AB

    Request for Sample

    Report Url http://www.reportsweb.com//age-related-macular-degeneration-pipeline-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//age-related-macular-degeneration-pipeline-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//age-related-macular-degeneration-pipeline-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments